866-997-4948(US-Canada Toll Free)

United States Orally Disintegrating Tablet Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 111 Pages

In this report, the United States Orally Disintegrating Tablet market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Orally Disintegrating Tablet in these regions, from 2013 to 2025 (forecast).

United States Orally Disintegrating Tablet market competition by top manufacturers/players, with Orally Disintegrating Tablet sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

Table of Contents

United States Orally Disintegrating Tablet Market Report 2018
1 Orally Disintegrating Tablet Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet
1.2 Classification of Orally Disintegrating Tablet by Product Category
1.2.1 United States Orally Disintegrating Tablet Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Orally Disintegrating Tablet Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Anti-Psychotics Drug
1.2.4 Anti-Epileptics Drug
1.2.5 Other
1.3 United States Orally Disintegrating Tablet Market by Application/End Users
1.3.1 United States Orally Disintegrating Tablet Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 United States Orally Disintegrating Tablet Market by Region
1.4.1 United States Orally Disintegrating Tablet Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.4.3 Southwest Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.4.5 New England Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.4.6 The South Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.4.7 The Midwest Orally Disintegrating Tablet Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Orally Disintegrating Tablet (2013-2025)
1.5.1 United States Orally Disintegrating Tablet Sales and Growth Rate (2013-2025)
1.5.2 United States Orally Disintegrating Tablet Revenue and Growth Rate (2013-2025)

2 United States Orally Disintegrating Tablet Market Competition by Players/Suppliers
2.1 United States Orally Disintegrating Tablet Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Orally Disintegrating Tablet Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Orally Disintegrating Tablet Average Price by Players/Suppliers (2013-2018)
2.4 United States Orally Disintegrating Tablet Market Competitive Situation and Trends
2.4.1 United States Orally Disintegrating Tablet Market Concentration Rate
2.4.2 United States Orally Disintegrating Tablet Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Orally Disintegrating Tablet Manufacturing Base Distribution, Sales Area, Product Type

3 United States Orally Disintegrating Tablet Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Orally Disintegrating Tablet Sales and Market Share by Region (2013-2018)
3.2 United States Orally Disintegrating Tablet Revenue and Market Share by Region (2013-2018)
3.3 United States Orally Disintegrating Tablet Price by Region (2013-2018)

4 United States Orally Disintegrating Tablet Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Orally Disintegrating Tablet Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Orally Disintegrating Tablet Revenue and Market Share by Type (2013-2018)
4.3 United States Orally Disintegrating Tablet Price by Type (2013-2018)
4.4 United States Orally Disintegrating Tablet Sales Growth Rate by Type (2013-2018)

5 United States Orally Disintegrating Tablet Sales (Volume) by Application (2013-2018)
5.1 United States Orally Disintegrating Tablet Sales and Market Share by Application (2013-2018)
5.2 United States Orally Disintegrating Tablet Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Orally Disintegrating Tablet Players/Suppliers Profiles and Sales Data
6.1 Teva
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Mylan
6.3.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Johnson and Johnson
6.5.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 GSK
6.6.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GSK Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Otsuka
6.7.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly and Company
6.8.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 AstraZeneca
6.9.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb
6.10.2 Orally Disintegrating Tablet Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Conquer

7 Orally Disintegrating Tablet Manufacturing Cost Analysis
7.1 Orally Disintegrating Tablet Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Orally Disintegrating Tablet

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Orally Disintegrating Tablet Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Orally Disintegrating Tablet Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Orally Disintegrating Tablet Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Orally Disintegrating Tablet Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Orally Disintegrating Tablet Sales Volume Forecast by Type (2018-2025)
11.3 United States Orally Disintegrating Tablet Sales Volume Forecast by Application (2018-2025)
11.4 United States Orally Disintegrating Tablet Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Orally Disintegrating Tablet
Figure United States Orally Disintegrating Tablet Market Size (M Units) by Type (2013-2025)
Figure United States Orally Disintegrating Tablet Sales Volume Market Share by Type (Product Category) in 2017
Figure Anti-Psychotics Drug Product Picture
Figure Anti-Epileptics Drug Product Picture
Figure Other Product Picture
Figure United States Orally Disintegrating Tablet Market Size (M Units) by Application (2013-2025)
Figure United States Sales Market Share of Orally Disintegrating Tablet by Application in 2017
Figure CNS Diseases Examples
Table Key Downstream Customer in CNS Diseases
Figure Gastrointestinal Diseases Examples
Table Key Downstream Customer in Gastrointestinal Diseases
Figure CVS Diseases Examples
Table Key Downstream Customer in CVS Diseases
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Orally Disintegrating Tablet Market Size (Million USD) by Region (2013-2025)
Figure The West Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Orally Disintegrating Tablet Sales (M Units) and Growth Rate (2013-2025)
Figure United States Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Orally Disintegrating Tablet Market Major Players Product Sales Volume (M Units) (2013-2018)
Table United States Orally Disintegrating Tablet Sales (M Units) of Key Players/Suppliers (2013-2018)
Table United States Orally Disintegrating Tablet Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Orally Disintegrating Tablet Sales Share by Players/Suppliers
Figure 2017 United States Orally Disintegrating Tablet Sales Share by Players/Suppliers
Figure United States Orally Disintegrating Tablet Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Orally Disintegrating Tablet Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers
Figure 2017 United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers
Table United States Market Orally Disintegrating Tablet Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Orally Disintegrating Tablet Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Orally Disintegrating Tablet Market Share of Top 3 Players/Suppliers
Figure United States Orally Disintegrating Tablet Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Orally Disintegrating Tablet Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Orally Disintegrating Tablet Product Category
Table United States Orally Disintegrating Tablet Sales (M Units) by Region (2013-2018)
Table United States Orally Disintegrating Tablet Sales Share by Region (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Share by Region (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Market Share by Region in 2017
Table United States Orally Disintegrating Tablet Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Orally Disintegrating Tablet Revenue Share by Region (2013-2018)
Figure United States Orally Disintegrating Tablet Revenue Market Share by Region (2013-2018)
Figure United States Orally Disintegrating Tablet Revenue Market Share by Region in 2017
Table United States Orally Disintegrating Tablet Price (USD/Unit) by Region (2013-2018)
Table United States Orally Disintegrating Tablet Sales (M Units) by Type (2013-2018)
Table United States Orally Disintegrating Tablet Sales Share by Type (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Share by Type (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Market Share by Type in 2017
Table United States Orally Disintegrating Tablet Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Orally Disintegrating Tablet Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Orally Disintegrating Tablet by Type (2013-2018)
Figure Revenue Market Share of Orally Disintegrating Tablet by Type in 2017
Table United States Orally Disintegrating Tablet Price (USD/Unit) by Types (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Growth Rate by Type (2013-2018)
Table United States Orally Disintegrating Tablet Sales (M Units) by Application (2013-2018)
Table United States Orally Disintegrating Tablet Sales Market Share by Application (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Market Share by Application (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Market Share by Application in 2017
Table United States Orally Disintegrating Tablet Sales Growth Rate by Application (2013-2018)
Figure United States Orally Disintegrating Tablet Sales Growth Rate by Application (2013-2018)
Table Teva Basic Information List
Table Teva Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Teva Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Teva Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Merck Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Merck Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Mylan Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Mylan Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Pfizer Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Pfizer Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Johnson and Johnson Basic Information List
Table Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson and Johnson Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Johnson and Johnson Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Johnson and Johnson Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure GSK Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure GSK Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Otsuka Basic Information List
Table Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Otsuka Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Otsuka Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Otsuka Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure AstraZeneca Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure AstraZeneca Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Orally Disintegrating Tablet Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Orally Disintegrating Tablet Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Orally Disintegrating Tablet Revenue Market Share in United States (2013-2018)
Table Conquer Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orally Disintegrating Tablet
Figure Manufacturing Process Analysis of Orally Disintegrating Tablet
Figure Orally Disintegrating Tablet Industrial Chain Analysis
Table Raw Materials Sources of Orally Disintegrating Tablet Major Players/Suppliers in 2017
Table Major Buyers of Orally Disintegrating Tablet
Table Distributors/Traders List
Figure United States Orally Disintegrating Tablet Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure United States Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Orally Disintegrating Tablet Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Type (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Type (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Type in 2025
Table United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Application (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Application (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Application in 2025
Table United States Orally Disintegrating Tablet Sales Volume (M Units) Forecast by Region (2018-2025)
Table United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region (2018-2025)
Figure United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *